Two Sigma Advisers’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Buy |
13,900
+1,900
| +16% | +$5.87K | ﹤0.01% | 2265 |
|
|
2025
Q1 | $41.9K | Hold |
12,000
| – | – | ﹤0.01% | 2330 |
|
|
2024
Q4 | $39.2K | Sell |
12,000
-1,200
| -9% | -$3.92K | ﹤0.01% | 2299 |
|
|
2024
Q3 | $50.8K | Sell |
13,200
-3,900
| -23% | -$15K | ﹤0.01% | 2214 |
|
|
2024
Q2 | $52.8K | Sell |
17,100
-500
| -3% | -$1.55K | ﹤0.01% | 2361 |
|
|
2024
Q1 | $45.4K | Sell |
17,600
-13,400
| -43% | -$34.6K | ﹤0.01% | 2352 |
|
|
2023
Q4 | $77.5K | Buy |
+31,000
| New | +$77.5K | ﹤0.01% | 2353 |
|
|
2023
Q3 | – | Sell |
-13,700
| Closed | -$31.5K | – | 2364 |
|
|
2023
Q2 | $31.5K | Buy |
+13,700
| New | +$31.5K | ﹤0.01% | 2302 |
|
|
2022
Q3 | – | Sell |
-64,400
| Closed | -$175K | – | 2521 |
|
|
2022
Q2 | $175K | Sell |
64,400
-171,800
| -73% | -$467K | ﹤0.01% | 2306 |
|
|
2022
Q1 | $704K | Sell |
236,200
-108,100
| -31% | -$322K | ﹤0.01% | 1815 |
|
|
2021
Q4 | $1.34M | Buy |
344,300
+228,500
| +197% | +$889K | ﹤0.01% | 1399 |
|
|
2021
Q3 | $497K | Sell |
115,800
-108,800
| -48% | -$467K | ﹤0.01% | 1928 |
|
|
2021
Q2 | $681K | Sell |
224,600
-196,600
| -47% | -$596K | ﹤0.01% | 1803 |
|
|
2021
Q1 | $1.4M | Buy |
+421,200
| New | +$1.4M | ﹤0.01% | 1457 |
|
|
2020
Q4 | – | Sell |
-24,100
| Closed | -$75K | – | 2362 |
|
|
2020
Q3 | $75K | Sell |
24,100
-142,600
| -86% | -$444K | ﹤0.01% | 2295 |
|
|
2020
Q2 | $303K | Buy |
166,700
+32,700
| +24% | +$59.4K | ﹤0.01% | 2114 |
|
|
2020
Q1 | $135K | Buy |
134,000
+53,000
| +65% | +$53.4K | ﹤0.01% | 2260 |
|
|
2019
Q4 | $225K | Buy |
81,000
+1,700
| +2% | +$4.72K | ﹤0.01% | 2152 |
|
|
2019
Q3 | $121K | Sell |
79,300
-7,100
| -8% | -$10.8K | ﹤0.01% | 2098 |
|
|
2019
Q2 | $180K | Buy |
86,400
+50,800
| +143% | +$106K | ﹤0.01% | 2150 |
|
|
2019
Q1 | $127K | Buy |
35,600
+19,200
| +117% | +$68.5K | ﹤0.01% | 2166 |
|
|
2018
Q4 | $63K | Buy |
16,400
+2,300
| +16% | +$8.84K | ﹤0.01% | 2264 |
|
|
2018
Q3 | $133K | Buy |
+14,100
| New | +$133K | ﹤0.01% | 2138 |
|